公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 |
---|---|---|---|---|---|---|
2007 | Clinical experience of 17 cases of imported malaria at a Taiwan university hospital, 1999-2005 | Chung H.-C.; JANN-TAY WANG ; HSIN-YUN SUN ; Wang J.-L.; Lo Y.-C.; WANG-HUEI SHENG ; SZU-MIN HSIEH ; CHI-TAI FANG ; PO-REN HSUEH ; YEE-CHUN CHEN ; SHAN-CHWEN CHANG | Journal of Microbiology, Immunology and Infection | 3 | 0 | |
2011 | A Cullin3-KLHL20 Ubiquitin Ligase-Dependent Pathway Targets PML to Potentiate HIF-1 Signaling and Prostate Cancer Progression | Yuan W.-C.; Lee Y.-R.; Huang S.-F.; Lin Y.-M.; Chen T.-Y.; Chung H.-C.; Tsai C.-H.; Chen H.-Y.; Chiang C.-T.; Lai C.-K.; Lu L.-T.; Chen C.-H.; Gu D.-L.; YEONG-SHIAU PU ; Jou Y.-S.; Lu K.; Hsiao P.-W.; Shih H.-M.; Chen R.-H. | Cancer Cell | 135 | 134 | |
2013 | Everolimus for previously treated advanced gastric cancer: Results of the randomized, double-blind, phase III GRANITE-1 study | Ohtsu A.; Ajani J.A.; Bai Y.-X.; Bang Y.-J.; Chung H.-C.; Pan H.-M.; Sahmoud T.; Shen L.; KUN-HUEI YEH ; Chin K.; Muro K.; Kim Y.H.; Ferry D.; Tebbutt N.C.; Al-Batran S.-E.; Smith H.; Costantini C.; Rizvi S.; Lebwohl D.; Van Cutsem E. | Journal of Clinical Oncology | 402 | 371 | |
2008 | Extremely high prevalence and genetic diversity of hepatitis C virus infection among HIV-infected injection drug users in Taiwan | Liu J.-Y.; Lin H.-H.; Liu Y.-C.; Lee S.S.-J.; Chen Y.-L.; CHIEN-CHING HUNG ; Ko W.-C.; Huang C.-K.; Lai C.-H.; Chen Y.-S.; Shih Y.-L.; Chung H.-C.; Liang S.-H.; Lin J.-N. | Clinical Infectious Diseases | 52 | 48 | |
2007 | Liver abscess due to Neisseria sicca after repeated transcatheter arterial embolization | Chung H.-C.; LEE-JENE TENG ; PO-REN HSUEH | Journal of Medical Microbiology | 11 | 7 | |
2012 | MiR-103/107 promote metastasis of colorectal cancer by targeting the metastasis suppressors DAPK and KLF4 | Chen H.-Y.; Lin Y.-M.; Chung H.-C.; Lang Y.-D.; Lin C.-J.; JOHN HUANG ; Wang W.-C.; Lin F.-M.; Chen Z.; Huang H.-D.; Shyy J.Y.-J.; JIN-TUNG LIANG ; Chen R.-H. | Cancer Research | 271 | 261 | |
2013 | Sunitinib versus sorafenib in advanced hepatocellular cancer: Results of a randomized phase III trial | ANN-LII CHENG ; Kang Y.-K.; Lin D.-Y.; Park J.-W.; Kudo M.; Qin S.; Chung H.-C.; Song X.; Xu J.; Poggi G.; Omata M.; Lowenthal S.P.; Lanzalone S.; Yang L.; Lechuga M.J.; Raymond E. | Journal of Clinical Oncology | 619 | 599 |